查看所有供应商和价格请点击:
1374853-91-4生产厂家
1374853-91-4价格
化源商城直购
[1]. Schachter J, et al. Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006). Lancet. 2017 Aug 16. pii: S0140-6736(17)31601-X.